Personal Genome Diagnostics, a Baltimore-based cancer diagnostics company, said in a regulatory filing it has raised $65 million in an ongoing equity financing round in which it hopes to raise $111.5 million.
{iframe}http://www.baltimoresun.com/business/bs-bz-personal-genome-diagnostics-20171103-story.html{/iframe}